Skip to search formSkip to main contentSkip to account menu

Bepridil

Known as: 1-(2-(N-Benzylanilino)-1-(Isobutoxymethyl)Ethyl)-Pyrrolidine, 1-Pyrrolidineethanamine, beta-((2-methylpropoxy)methyl)-N-phenyl-N-(phenylmethyl)-, 1-Pyrrolideneethanamine, Beta-((2-Methylpropoxy)Methyl)-N-Phenyl-N-(Phenylmethyl)- 
A long-acting calcium-blocking agent with significant anti-anginal activity. The drug produces significant coronary vasodilation and modest… 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Highly Cited
1987
Highly Cited
1987
Fourteen patients with established atrial fibrillation (longer than three months) that was refractory to treatment were studied… 
1986
1986
The electrophysiological actions of bepridil were compared with those of disopyramide in rabbit atrial, Purkinje, and papillary… 
1985
1985
The effects of bepridil, a calcium antagonist with a half-life of approximately 42 hr, were assessed in a double-blind… 
1985
1985
The effects of verapamil and bepridil on occlusion and reperfusion ventricular arrhythmias including ventricular fibrillation (VF… 
1984
1984
Using radiolabelled bepridil, equilibrium dialysis experiments and direct ligand-binding studies were conducted to characterize… 
1982
1982
Summary The efflux and uptake of (3H]Ca antagonists were studied in isolated rings of rabbit aorta. The efflux of [3H]bepridil… 
1981
1981
Summary We investigated the potential antidysrhythmic effects of bepridil, a new antianginal agent, on dysrhythmias of… 
1981
1981
The antiarrhythmic effects of a novel antianginal agent, bepridil, were compared with four reference products. Bepridil increased… 
1978
1978
The effects of amiodarone, perhexiline and bepridil, which decrease effort cardioacceleration although they have no adrenergic… 
1977